How to use the speech recognition tool?

NCT03584243

TE-CXL

Transepithelial Corneal Collagen Crosslinking in Eyes With Progressive Keratoconus (TE-CXL)

Type: Interventional



Status of the trial: Active, Not recruiting

Orphan Drug Recognition: No

Inclusion

  • Opening Date: 2017-12-01
  • Closing Date: 2019-06-01

Criteria

More information

Children: No

Adults: Yes

Funder Type: public

HCP: Other investigators


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Anterior Segment Rare Eye Diseases (WG4)

Subscribe to our mailing list

* indicates required

This ERN is supported by: